193 related articles for article (PubMed ID: 22909956)
1. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy.
Heikkilä HP; Krafft E; Jespers P; McEntee K; Rajamäki MM; Clercx C
Vet J; 2013 Apr; 196(1):52-6. PubMed ID: 22909956
[TBL] [Abstract][Full Text] [Related]
2. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
[TBL] [Abstract][Full Text] [Related]
3. Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis.
Krafft E; Heikkilä HP; Jespers P; Peeters D; Day MJ; Rajamäki MM; Mc Entee K; Clercx C
J Vet Intern Med; 2011; 25(5):990-6. PubMed ID: 21781169
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of bronchoalveolar lavage fluid samples obtained from West Highland White Terriers with idiopathic pulmonary fibrosis, dogs with chronic bronchitis, and healthy dogs.
Lilja-Maula LI; Palviainen MJ; Heikkilä HP; Raekallio MR; Rajamäki MM
Am J Vet Res; 2013 Jan; 74(1):148-54. PubMed ID: 23270360
[TBL] [Abstract][Full Text] [Related]
6. Type III and type I procollagen markers in fibrosing alveolitis.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
[TBL] [Abstract][Full Text] [Related]
7. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
Schaberg T; Orzechowski K; Oesterling C; Lode H; Schuppan D
Eur Respir J; 1994 Jul; 7(7):1221-6. PubMed ID: 7925898
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
Milman N; Kristensen MS; Bentsen K
APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of type III procollagen N-terminal peptides in BAL fluid from normal and fibrotic lungs.
Harrison NK; McAnulty RJ; Kimpton WG; Fraser JR; Laurent TC; Laurent GJ
Eur Respir J; 1993 Nov; 6(10):1443-8. PubMed ID: 8112436
[TBL] [Abstract][Full Text] [Related]
11. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
Cantin AM; Boileau R; Bégin R
Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
[TBL] [Abstract][Full Text] [Related]
12. N-terminal propeptide of type III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia.
Heikinheimo M; Halila R; Marttinen E; Raivio K
Pediatr Res; 1992 Apr; 31(4 Pt 1):340-3. PubMed ID: 1570200
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
[TBL] [Abstract][Full Text] [Related]
14. Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Ruotsalainen EM; Lähde S; Kinnula VL
Eur Respir J; 1999 Sep; 14(3):560-4. PubMed ID: 10543275
[TBL] [Abstract][Full Text] [Related]
15. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
[TBL] [Abstract][Full Text] [Related]
16. Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome.
Farjanel J; Hartmann DJ; Guidet B; Luquel L; Offenstadt G
Am Rev Respir Dis; 1993 May; 147(5):1091-9. PubMed ID: 8484615
[TBL] [Abstract][Full Text] [Related]
17. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.
Low RB; Giancola MS; King TE; Chapitis J; Vacek P; Davis GS
Am Rev Respir Dis; 1992 Sep; 146(3):701-6. PubMed ID: 1519851
[TBL] [Abstract][Full Text] [Related]
18. Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease.
Hezzell MJ; Falk T; Olsen LH; Boswood A; Elliott J
J Vet Cardiol; 2014 Dec; 16(4):257-64. PubMed ID: 25292459
[TBL] [Abstract][Full Text] [Related]
19. Measurement of serum carboxyterminal cross-linked telopeptide of type I collagen concentration in dogs with osteosarcoma.
Hintermeister JG; Jones PD; Hoffmann WE; Siegel AM; Dervisis NG; Kitchell BE
Am J Vet Res; 2008 Nov; 69(11):1481-6. PubMed ID: 18980431
[TBL] [Abstract][Full Text] [Related]
20. Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients.
Hiwatari N; Shimura S; Yamauchi K; Nara M; Hida W; Shirato K
Tohoku J Exp Med; 1997 Feb; 181(2):285-95. PubMed ID: 9163845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
